JAK inhibitors

JAK inhibitors are a class of medications that block specific enzymes called Janus kinases (JAKs). These enzymes play a key role in the body’s immune response and inflammation processes. By inhibiting JAKs, these drugs help reduce inflammation and symptoms associated with various autoimmune diseases, such as rheumatoid arthritis, psoriasis, and ulcerative colitis. They work by interrupting the signaling pathways that lead to inflammatory responses, thereby helping to manage conditions where the immune system mistakenly attacks the body’s own tissues. Overall, JAK inhibitors can improve quality of life for people with certain chronic inflammatory diseases.